Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [912]

Checkpoint machinery protects against cancer

Prof Jiri Bartek - Danish Cancer Society Research Centre, Copenhagen, Denmark

Checkpoint machinery protects against cancer ( Prof Jiri Bartek - Danish Cancer Society Research Centre, Copenhagen, Denmark )

Connections between DNA-PK, ATM, ATR and mTOR dependent pathways

Prof Marco Foiani - Scientific director, IFOM, Milan

Connections between DNA-PK, ATM, ATR and mTOR dependent pathways ( Prof Marco Foiani - Scientific director, IFOM, Milan )

What is the potential of TOR inhibition for cancer therapy?

Dr Mike Hall - University of Basel, Basel, Switzerland

What is the potential of TOR inhibition for cancer therapy? ( Dr Mike Hall - University of Basel, Basel, Switzerland )

Mathematical modelling can be used in cancer therapy

Dr Arne Lindqvist - Karolinska Institutet

Mathematical modelling can be used in cancer therapy ( Dr Arne Lindqvist - Karolinska Institutet )

Recombination can drive tumourogenesis

Prof James Haber - Brandeis University, Waltham, USA

Recombination can drive tumourogenesis ( Prof James Haber - Brandeis University, Waltham, USA )

The role of the PI3K and TOR pathways in cancer

Dr David Fruman - University of California, Irvine, USA

The role of the PI3K and TOR pathways in cancer ( Dr David Fruman - University of California, Irvine, USA )

What is the link between mechanobiology and cancer?

Prof Michael Sheetz - National University of Singapore and Columbia University

What is the link between mechanobiology and cancer? ( Prof Michael Sheetz - National University of Singapore and Columbia University )

TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy

Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX

TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )

Editor's choice for December 2015

Prof Gordon McVie - ecancer Editor

Editor's choice for December 2015 ( Prof Gordon McVie - ecancer Editor )

“Low but real” risk of myelodysplastic syndromes caused by thyroid cancer...

Dr Sudipto Mukherjee - Cleveland Clinic, Cleveland, USA

“Low but real” risk of myelodysplastic syndromes caused by thyroid cancer treatment ( Dr Sudipto Mukherjee - Cleveland Clinic, Cleveland, USA )

How can functional drug screening guide personalised cancer therapy?

Prof Jeff Tyner - Oregon Health & Science University, Portland, USA

How can functional drug screening guide personalised cancer therapy? ( Prof Jeff Tyner - Oregon Health & Science University, Portland, USA )

How do genes influence the development of chronic idiopathic thrombocytopenic...

Prof Jenny Despotovic - Texas Children's Cancer Center, Houston, USA

How do genes influence the development of chronic idiopathic thrombocytopenic purpura? ( Prof Jenny Despotovic - Texas Children's Cancer Center, Houston, USA )

More from ecancer